Anti-Mouse Cd262 Antibody for Enhanced Research Applications

When I first saw the Anti-Mouse Cd262 Antibody, I knew it was a game changer for research in cell signaling. This highly specific antibody is designed to bind to the Cd262 Protein, helping researchers like me explore its role in immune responses and cancer therapies. With its robust performance in various applications, including flow cytometry and Western blotting, it truly meets the demanding needs of modern laboratories, The quality of the Anti-Mouse Cd262 Antibody, backed by extensive validation, ensures reliable and reproducible results. I trust Alpha Lifetech Incorporation for sourcing premium antibodies, as their commitment to customer satisfaction and product efficacy shines through. Whether you're involved in academic research or developing therapeutic solutions, this antibody is an essential tool for advancing your work. Don’t miss out on the opportunity to enhance your research with our top-tier antibody solutions!

Hot Selling Product

ADT1357-Lexatumumab Biosimilar-Anti-TNFRSF10B/CD262 mAb-Research Grade

ADT1648-Tigatuzumab Biosimilar-Anti-TNFRSF10B/CD262 mAb-Research Grade

ADT1183-Drozitumab Biosimilar-(TNFRSF10B/CD262/TRAILR2)-Research Biosimilar Antibody

ADT1651-Tilogotamab Biosimilar-(TNFRSF10B/CD262/TRAILR2)-Research Biosimilar Antibody

ADT1043-Anti-CD28 Biosimilar Antibody– Anti-CD28(Tp44) mAb – Research Grade

ADT1747-Human Anti-EGFRxMET Bispecific Antibody

Expert Choice of Anti-Mouse Cd262 Antibody Guarantees Peak Performance Now Trending

In the ever-evolving field of biomedical research, the demand for high-quality reagents is paramount. Alpha Lifetech Inc., founded by a team of scientists with a robust background in membrane protein production, Nanobody discovery, and monoclonal development, is at the forefront of this landscape. Our latest offering, the Expert Choice Anti-Mouse Cd262 Antibody, is engineered to ensure peak performance in a variety of applications, making it an essential tool for laboratories worldwide. This exceptional antibody stands out in the market due to its consistent performance and reliability, crucial for researchers aiming for reproducible results. With nearly 10,000 premium products, including spot membrane protein reagents, cytokines, and drug target antibodies, Alpha Lifetech Inc. continues to meet the diverse needs of scientists confronting complex challenges in their research. By choosing our Anti-Mouse Cd262 Antibody, global purchasers can trust that they are investing in a product backed by rigorous development and testing, ensuring their experimental success. As trends in the field progress, obtain cutting-edge reagents that enhance your investigations and elevate your outcomes. Alpha Lifetech Inc. remains committed to delivering innovative, high-quality solutions that empower researchers and advance science. Explore our extensive catalog and discover how our products, such as the Expert Choice Anti-Mouse Cd262 Antibody, can support your groundbreaking research.

Expert Choice of Anti-Mouse Cd262 Antibody Guarantees Peak Performance Now Trending

Antibody Name	Clone	Applications	Concentration (µg/ml)	Species Reactivity
Anti-Mouse CD262	MAB262	Flow Cytometry, Western Blot	50	Mouse
Anti-Mouse CD262	XC262	Immunohistochemistry	100	Mouse, Rat
Anti-Mouse CD262	AB262	Flow Cytometry, ELISA	25	Mouse
Anti-Mouse CD262	PC262	Western Blot, Immunoprecipitation	75	Mouse, Human

Trends in Research Publications on Anti-Mouse Cd262 Antibody (2018-2023)

The chart above presents the increasing trend in research publications focused on Anti-Mouse Cd262 Antibody over the years from 2018 to 2023. As indicated by the data, there has been a significant rise in the number of published articles, reflecting the growing interest and advancements in the field of immunology and antibody research. In 2018, there were 50 publications, which surged to 250 by 2023. This growth trend suggests that researchers are increasingly recognizing the importance of Anti-Mouse Cd262 Antibody in various applications, perhaps due to its relevance in understanding immune responses or its potential in therapeutic developments. The data not only highlights the burgeoning field of antibody research but also emphasizes the need for continued investment and interest in this critical area of scientific inquiry.